Mr. Yao Yiming, the president of Suzhou Ronnsi Pharma Co., Ltd., a leading talent in science and technology in Suzhou Industrial Park, and a leading talent in innovation and entrepreneurship in Suzhou.

In 1989, Mr. Yao Yiming received his bachelor degree from Nanjing University. From 1989 to 1994, he worked as an engineer in the State Key Laboratory of Coordination Chemistry of Nanjing University. In 1997, he received his master degree in Chemistry from the University of Alberta, Canada. Then he has been engaged in the development of new drugs and processes in North America for more than ten years. During this period, he successively served as a senior researcher of Dalton Pharmaceutical, Altus Pharmaceutical and Momenta Pharmaceutical, engaged in the research and development of heparin drugs, chiral drug synthesis, enzyme catalysis, protein nucleic acid structure and other complex molecular drugs.  Founded Boaopharma, Inc., USA, 2006-2012  And president;  In 2012, he returned to China and founded Suzhou Ronnsi Pharma Co., Ltd., and has served as the president of the company since then.  Mr. Yao's main scientific research achievements include: the development of enzyme catalytic technology for several new drugs on the market, M118 (from research and development to clinical phase II), ovine enoxarin sodium (patented new drug, treatment of thrombotic diseases) and polysea ginseng glycosaminoglycan (a class of innovative drugs, anti-tumor metastasis, anti-alzheimer's disease), etc.  He has published more than 30 academic papers and more than 10 patents.